The novel treatment of the medication represents a exciting advance in the management of the condition. Unlike existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatidepeptide010106.blogchaat.com/42309115/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment